BioLineRx Announces Underwritten Public Offering of its American Depositary Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
BioLineRx (BLRX) Prices 12.5M Public Offering at $2/ADS
March 6, 2015 9:05 AM ESTBioLineRx (NASDAQ: BLRX) announced that it has priced an underwritten public offering of 12,500,000 American Depositary Shares (ADSs), each representing ten (10) of its Ordinary Shares, at a public offering price of $2.00 per ADS for gross proceeds of $25 million. All of the ADSs in the... More
BioLineRx (BLRX) Announces ADS Offering
March 5, 2015 4:51 PM ESTBioLineRx (NASDAQ: BLRX) announced that it has commenced an underwritten public offering of American Depositary Shares ("ADSs"), each representing ten (10) of its Ordinary Shares. All of the ADSs in the offering are to be sold by BioLineRx.
JMP Securities is acting as sole... More
